Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 20Pancreatic Ductal Adenocarcinoma 2Jaundice, Obstructive 2Gastroparesis 2Peritoneal Diseases 1Periampullary Cancer 1Pancreatic Adenocarcinoma 1Obesity 1Metabolic Syndrome 1Locally Advanced Pancreatic Adenocarcinoma 1Hypoxia 1Gastrointestinal Stromal Tumor of Duodenum 1Diabetes Mellitus 1Bile Duct Neoplasms 1Adenocarcinoma 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Photochemotherapy 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Dihematoporphyrin Ether 3Dexamethasone 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2regorafenib 2olaparib 2dehydroftorafur 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Bile Duct Neoplasms × Pancreaticoduodenectomy × Clear all
NCT04763642 2026-01-21

The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone

State Budget Public Health Institution Scientific Research Institute - Ochapovsky Regional Clinical Hospital

Phase NA Completed
320 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡